Wobble Genomics Reveals Advances in HER2 Profiling at SABCS 2025 Wobble Genomics showcases its innovative platform for detailed HER2 profiling in breast cancer at SABCS 2025, offering new precision in diagnostics.

Wobble Genomics Reveals Advances in HER2 Profiling at SABCS 2025 #United_Kingdom #Edinburgh #Cancer_Diagnostics #Wobble_Genomics #HER2_profiling

Wobble Genomics Unveils Innovative Liquid Biopsy Technology at ESMO 2025 Wobble Genomics showcased groundbreaking advancements in cancer diagnostics at ESMO 2025, featuring a sensitive liquid biopsy platform for RNA detection.

Wobble Genomics Unveils Innovative Liquid Biopsy Technology at ESMO 2025 #United_Kingdom #Cancer_Diagnosis #Liquid_Biopsy #Edinburgh #Wobble_Genomics

Wobble Genomics Appoints Dr. Dietrich A. Stephan as Chairman of the Board Wobble Genomics announces Dr. Dietrich A. Stephan as the new Chairman of the Board, enhancing its mission to advance cancer diagnostics.

Wobble Genomics Appoints Dr. Dietrich A. Stephan as Chairman of the Board #United_Kingdom #Edinburgh #Wobble_Genomics #Dietrich_Stephan #cfRNA_technology